openPR Logo
Press release

Global Influenza Vaccine Market to Reach US$ 22.71 Billion by 2032, Growing at a CAGR of 11.07% | Astute Analytica

07-11-2024 09:47 AM CET | Health & Medicine

Press release from: Astute Analytica

Global Influenza Vaccine Market to Reach US$ 22.71 Billion

The global ๐ข๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐ณ๐š ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ, which was valued at ๐”๐’$ ๐Ÿ–.๐Ÿ•๐Ÿ– ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘, is projected to witness substantial growth, reaching a market valuation of ๐”๐’$ ๐Ÿ๐Ÿ.๐Ÿ•๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. This impressive expansion is expected to occur at a compound annual growth rate (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ๐Ÿ.๐ŸŽ๐Ÿ•% during the forecast period from ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐“๐ก๐ž ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž- https://www.astuteanalytica.com/request-sample/influenza-vaccine-market

The increasing prevalence of influenza, rising awareness about the importance of vaccination, and advancements in vaccine technology are some of the key factors driving the growth of the influenza vaccine market. Moreover, government initiatives and funding to promote vaccination and the presence of robust healthcare infrastructure further boost market growth.

As the world continues to combat seasonal influenza outbreaks and prepares for potential pandemics, the demand for effective influenza vaccines is on the rise. Pharmaceutical companies are investing heavily in research and development to create more effective and longer-lasting vaccines, addressing the evolving strains of the influenza virus.

The projected growth of the influenza vaccine market reflects the ongoing efforts and advancements in the healthcare sector to protect populations globally. With continuous innovations and strategic collaborations, the market is set to achieve significant milestones in the coming years.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

The global Influenza Vaccine Market is expected to witness substantial growth between 2022 and 2030, with a positive outlook for 2022 and beyond. Key players in the industry are adopting effective strategies, which are anticipated to further expand the market and create numerous opportunities for advancement.

๐๐ฒ ๐“๐ฒ๐ฉ๐ž

Inactivated influenza vaccine (IIV)
Quadrivalent
Trivalent
Live-attenuated influenza vaccine (LAIV)
By Process

Egg Based
Cell Culture-Based
Recombinant
By Route of Administration

Injectable
Intra-nasal
By Age Group

Pediatric
Adult
By Distribution Channel

Hospitals & Pharmacies
Government Suppliers
Others
By Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of MEA
South America
Argentina
Brazil
Rest of South America

๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ข๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐ณ๐š ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ง๐ ๐ข๐ญ๐ฌ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ฉ๐ซ๐จ๐ฌ๐ฉ๐ž๐œ๐ญ๐ฌ, ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž ๐ฏ๐ข๐ฌ๐ข๐ญ:- https://www.astuteanalytica.com/industry-report/influenza-vaccine-market

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

The report highlights the key players in the Influenza Vaccine Market, offering valuable insights through detailed company profiles. These profiles encompass descriptions, business overviews, revenue insights, gross margins, product offerings, recent developments, historical data, and more.

Abbott Laboratories
AstraZeneca
Emergent BioSolutions Inc
Emergex Vaccines Holding Limited
GSK plc
Merck & Co., Inc.
OSIVAX
Pfizer Inc.
Sanofi SA
CSL Limited
Sinovac Biotech Ltd.
SK bioscience Co., Ltd.
Viatris Inc.
Other Prominent Players
The report provides several reasons to invest in it, including:

๐‹๐ž๐ฏ๐ž๐ซ๐š๐ ๐ข๐ง๐  ๐ƒ๐š๐ญ๐š ๐ญ๐จ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐‚๐ก๐จ๐ข๐œ๐ž๐ฌ ๐š๐ง๐ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ: The report offers valuable insights into industry trends, consumer behavior, and competitor analysis, enabling companies to make informed decisions about product development, pricing, and marketing strategies.

๐…๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐ง๐  ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซ ๐Œ๐ฎ๐ฅ๐ญ๐ข๐ฉ๐ฅ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ๐ฌ: By identifying market gaps and opportunities, the report helps companies differentiate themselves from competitors and gain a competitive advantage.

๐‚๐จ๐ง๐๐ฎ๐œ๐ญ๐ข๐ง๐  ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ๐ฌ: The report provides a thorough understanding of the market and its dynamics, allowing companies to compare and benchmark their performance against key competitors.

๐†๐š๐ข๐ง๐ข๐ง๐  ๐ƒ๐ž๐ž๐ฉ๐ž๐ซ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ๐ฌ' ๐…๐ข๐ง๐š๐ง๐œ๐ข๐š๐ฅ ๐๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐š๐ง๐œ๐ž: The report offers insights into competitors' financial performance, enabling companies to make informed decisions and minimize risk.

๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ข๐ง๐  ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐š๐ง๐ ๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ: The report provides insights into regional and country-specific strategies for business development, helping companies tailor their approaches to specific markets.

In summary, the Global Influenza Vaccine Market Report 2023 offers a comprehensive analysis of the Influenza Vaccine Market, including market size, segmentation, key players, and growth strategies. It provides valuable insights for businesses to make informed decisions, gain a competitive advantage, and maximize profits.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ@-https://www.astuteanalytica.com/request-sample/influenza-vaccine-market

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us
Phone number: +18884296757
Email: sales@astuteanalytica.com
Visit our website: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Influenza Vaccine Market to Reach US$ 22.71 Billion by 2032, Growing at a CAGR of 11.07% | Astute Analytica here

News-ID: 3575927 • Views: โ€ฆ

More Releases from Astute Analytica

Gum grafting market is set to reach valuation of US$ 892.9 million by 2033 | Astute Analytica
Gum grafting market is set to reach valuation of US$ 892.9 million by 2033 | Ast โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Gum grafting market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Gum grafting market. It highlights key trends and emerging opportunities while addressingโ€ฆ
Hospitals infection therapeutics market is poised to reach US$ 14.7 billion by 2033 | Astute Analytica
Hospitals infection therapeutics market is poised to reach US$ 14.7 billion by 2 โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Hospital infection therapeutics market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Hospital infection therapeutics market. It highlights key trends and emerging opportunitiesโ€ฆ
Radiopharmaceuticals market is poised to attain valuation of US$ 13.4 billion by 2033 | Astute Analytica
Radiopharmaceuticals market is poised to attain valuation of US$ 13.4 billion by โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Radiopharmaceuticals market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Radiopharmaceuticals market. It highlights key trends and emerging opportunities while addressing challenges facedโ€ฆ
Hospital supplies market size is set to expand beyond US$ 125.56 billion by 2033 | Astute Analytica
Hospital supplies market size is set to expand beyond US$ 125.56 billion by 2033 โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Hospital supplies market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Hospital supplies market. It highlights key trends and emerging opportunities while addressingโ€ฆ

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at ย https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: ย AstraZeneca ย Bharat Biotech ย Dynavax Technologies Corporation ย GlaxoSmithKline ย Johnson & Johnson ย Merck and Co ย Novartis ย Pfizer ย Sanofi Pasteur ย Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusingโ€ฆ
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the โ€œUnivers โ€ฆ
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, marketโ€ฆ
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, topโ€ฆ
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on โ€œInfluenza Vaccines in the United States โ€“ Market Size, Trends, Opportunities and Growth Potentialโ€ delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyzeโ€ฆ
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by theโ€ฆ
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled โ€œPaediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 โ€“ 2026โ€, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportionโ€ฆ